• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP ENHANCED ESTRADIOL (EE2)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP ENHANCED ESTRADIOL (EE2) Back to Search Results
Model Number N/A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/23/2017
Event Type  malfunction  
Manufacturer Narrative
The cause for the enhanced estradiol (ee2) results is unknown.Siemens healthcare diagnostics is investigating.The ifu states in the interpretation of results section: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings.".
 
Event Description
A false high advia centaur xp enhanced estradiol (ee2) result was obtained on a patient sample.The patient sample was repeated and the result was high.The patient sample was tested on an alternate method and the result was lower.The customer had two samples from the same patient and tested the samples on the advia centaur xp.The results were high.Both samples were tested on the alternate method and the results were lower.The customer tested the sample neat and with heterophilic blocking tube (hbt).The neat result was higher than the hbt result.The alternate method results were considered correct.Patient treatment was not prescribed or altered.There was no report of adverse health consequences as a result of these discordant enhanced estradiol results.
 
Manufacturer Narrative
Siemens filed the initial mdr 1219913-2017-00117 on may 9, 2017.On 06/13/2017 additional information: the patient sample is not available for further internal investigation.No information is known about medications or supplements taken by the patient.While the exact cause of the falsely elevated estradiol results cannot be determined, a non-specific interferent can not be ruled out.Immunoassays are subject to a number of interferences including those caused by endogenous antibodies.Interference can occur because of heterophile antibodies, anti-animal antibodies and auto antibodies.Patients exposed to animals or animal serum products can be prone to this interference and anomalous values may be observed.The interfering antibodies can give rise to a falsely high or less commonly a falsely low result.The erroneous result is recognized as being inconsistent with the patient's clinical picture.Please note the interferent may not necessarily be due to an interfering antibody but may be due to other exogenous interferences such as drugs, nutritional supplements and/or herbal medicine in the blood.The cause for the enhanced estradiol (ee2) results is unknown.The instrument is performing within specifications.No further evaluation of the device is required.The ifu states in the limitations section: "heterophilic antibodies in human serum can react with reagent immunoglobulins, interfering with in vitro immunoassays.Patients routinely exposed to animals or to animal serum products can be prone to this interference and anomalous values may be observed.Additional information may be required for diagnosis.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR XP ENHANCED ESTRADIOL (EE2)
Type of Device
ENHANCED ESTRADIOL
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
333 coney street
e. walpole MA 02032
Manufacturer Contact
eiman sulieman
333 coney street
e. walpole, MA 02032
5086604603
MDR Report Key6554029
MDR Text Key74831958
Report Number1219913-2017-00117
Device Sequence Number1
Product Code CHP
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 07/11/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/29/2017
Device Model NumberN/A
Device Catalogue Number10490889
Device Lot Number127035
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/17/2017
Initial Date FDA Received05/09/2017
Supplement Dates Manufacturer Received06/13/2017
Supplement Dates FDA Received07/11/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age52 YR
-
-